Danbury, Conn.-based Nuvance Health reported a $98.1 million operating loss (-3.4% margin) in fiscal year 2024, which ended Sept. 30, improving on a $164.2 million loss (-6.2% margin) in the year prior.
Category: Channels
The next growth opportunity for outpatient GI
The capsule endoscopy market has shown significant growth in recent years due to the increased prevalence of gastrointestinal disorders and the growing preference for non-invasive diagnostic procedures, according to a recent market report.